Publications
12
Citations
84
Est. group size
—
Recurring co-author estimate
Active years
10
Publishing since 2016
Heather Francis conducts biomedical research focused on liver and biliary (bile duct) diseases, studying how molecules such as bile acids, hormones, and signaling pathways drive liver inflammation, scarring (fibrosis), and tissue overgrowth. Much of this work uses mouse models to test potential treatments for chronic liver damage. A separate strand of earlier work addressed sexual and reproductive health research within specific community populations.
Publication activity has been low and irregular over the decade, with a peak of five papers in 2022 and otherwise one or fewer per year.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- INVA8001, a Novel and Highly Selective Chymase Inhibitor, Ameliorates Liver Inflammation, Fibrosis, and Hyperplasia in <i>Mdr2</i> Knockout Mice
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Conjugated Bile Acids activate Reactive Oxygen Species‐p90RSK‐Vascular Endothelial Growth Factor Receptor 3 signaling axis to promote lymphangiogenesis
The FASEB Journal · 2022
- The protective effects of estrogen on biliary and liver damage are independent of ER‐β signaling in female Mdr2 <sup>‐/‐</sup> mice
The FASEB Journal · 2022
- Suppression of MT1 and Melatonin Treatment Improves Liver Phenotypes in Mdr2 <sup>‐/‐</sup> mice
The FASEB Journal · 2022
- If You Build It, They Will Come: Feasibility of Sexual Health Research Among Individuals Married Within the Latter Day Saint Faith
Sexuality & Culture · 2016
- The FASEB Journal×5
- The Gerontologist×1
- Family Relations×1
- Comprehensive physiology×1
- Journal of American College Health×1
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile